Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N8EI
|
||||
Former ID |
DNC008445
|
||||
Drug Name |
4-(butyl(methyl)amino)-N-(quinolin-3-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529389] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H23N3O
|
||||
Canonical SMILES |
CCCCN(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2
|
||||
InChI |
1S/C21H23N3O/c1-3-4-13-24(2)19-11-9-16(10-12-19)21(25)23-18-14-17-7-5-6-8-20(17)22-15-18/h5-12,14-15H,3-4,13H2,1-2H3,(H,23,25)
|
||||
InChIKey |
UYXXRZNAVMFMMG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529389] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.